Drugdiscovery >> Drugs >> News
1382
Views
From Acid Reflux to Heart Disease? - drugdiscovery.com
From Acid Reflux to Heart Disease? - drugdiscovery.com


Latest research shows that regularly taken, proton pump inhibitors could lead to hypertension and weakened heart.
Read More >>


Tags: Acid reflux, proton pump inhibitors, Nexium, Prevacid, Prilosec - August 4, 2013
Related Articles
1494
Views
Official Nexium YouTube Channel Official Nexium YouTube Channel
Nexium maker, AstraZeneca, has decided to launch an official YouTube video to educate patients about Nexium. Read More >>

Tags: Nexium, GERD, Acid Reflux

3191
Views
Warfarin may increase the risk of heart attack Warfarin may increase the risk of heart attack
A long-term use of warfarin causes Vitamin K deficiency which affects blood clotting. Recent findings suggest that it may affect much more, such as causing osteopoorosis and calcification of organs t Read More >>

Tags: warfarin, side effects, long-term use, Vitamin K, heart attack, calcification of organs, osteoporosis

3284
Views
What Nexium is Used For? What Nexium is Used For?
Nexium, or esomeprasole, is a medication that falls into a class of drugs called proton pump inhibitors. Proton pumps line an area of the stomach where hydrochloric acid needed for digestion is produc Read More >>

Tags: nexium, chronic heartburn, reflux

3347
Views
Digoxin linked to higher risk of death in patients with systolic heart failure Digoxin linked to higher risk of death in patients with systolic heart failure
Latest study found an association between the use of a drug commonly used to treat heart conditions, digoxin, and a higher rate of death among adults with newly diagnosed systolic heart failure. Read More >>

Tags: digoxin, rate of death, risk, death, systolic heart failure

4693
Views
Vedolizumab shows promise in treating severe inflammatory bowel disease Vedolizumab shows promise in treating severe inflammatory bowel disease
The results of two separate studies show that Vedolizumab, a humanized monoclonal antibody that selectively blocks gut lymphocyte trafficking, is effective as induction and maintenance therapy for ul Read More >>

Tags: ulcerative colitis, Crohn’s disease, clinical trial, vedolizumab, inflamatory bowel disease

4579
Views
Risedronate shows promise in treating brittle bone disease in children Risedronate shows promise in treating brittle bone disease in children
The results of phase III clinical trial have showed that risedronate, previously used to treat osteoporosis in adults, significantly reduces the risk of clinical fracture in children with osteogenesi Read More >>

Tags: osteogenesis imperfecta, brittle bone disease, risedonate, treatment

3572
Views
No recommendation for tolvaptan for treatment of ADPKD in US No recommendation for tolvaptan for treatment of ADPKD in US
The FDA’s advisory committee decided not to recommend Otsuka’s drug tolvaptan for the indication of slowing kidney disease in adults at risk for rapidly progressing autosomal dominant polycystic Read More >>

Tags: Otsuka,tolvaptan, kidney disease, rapidly progressing autosomal dominant polycystic kidney disease, kidney, polycystic

6220
Views
Zerenex, a promising drug for treating chronic kidney disease Zerenex, a promising drug for treating chronic kidney disease
Keryx Biopharmaceuticals has submitted a New Drug Application to the FDA. The drug is iron-based phosphate binder Zerenex, which showed impressive results in a phase III trial in treating elevated s Read More >>

Tags: Keryx Biopharmaceuticals, Zerenex, chronic kidney disease

6842
Views
Thetanix, orphan drug for pediatric Crohn's disease Thetanix, orphan drug for pediatric Crohn's disease
The FDA has granted Orphan Drug Designation to GT Biologics for its drug Thetanix (bacteroides thetaiotaomicron) for paediatric Crohn’s disease. Read More >>

Tags: paediatric, Crohn’s disease, children, drug, orphan drug, Thetanix, GT Biologic

4089
Views
Triferic - a trade name of Rockwell Medical's chronic kidney disease drug Triferic - a trade name of Rockwell Medical's chronic kidney disease drug
The FDA has accepted the proposed proprietary trade name for the Rockwell Medical's soluble ferric pyrophosphate (SFP), an investigational iron-delivery drug intended for treating iron deficiency in Read More >>

Tags: Triferic, chronic kidney disease, iron deficiency, new drug, Rockwell Medical, soluble ferric pyrophosphate

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013